D-1508-2020 Class II Terminated
FDA drug recall D-1508-2020 was initiated by Lannett Company, Inc. on Aug 10, 2020 and is designated Class II. Reason for recall: Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg The recall status is terminated (terminated Jul 22, 2022).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 26, 2020
- Initiation Date
- Aug 10, 2020
- Termination Date
- Jul 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, Manufactured by: Tianjin Tianyao Pharmaceuticals Co., Ltd No. 221 Huanghai Road, Tianjin Economical-Technological Development Area, Tianjin, China 300457 NDC 0527-2931-37
Reason for recall
Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg
Distribution pattern
US Nationwide
Code information
Batch Number PE190701e1 with expiry June 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1508-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026